Literature DB >> 1328688

Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

W J Britt1, L G Vugler.   

Abstract

The disulfide-linked glycoprotein B (gB; gp55-116) complex of human cytomegalovirus represents the most abundant and immunogenic component of the virion envelope. We have studied the oligomerization and transport of this molecule, using a series of murine monoclonal antibodies. Our results indicated that oligomerization of this molecule occurred shortly after its synthesis, with a half-time of maximal formation of approximately 25 min. The oligomeric form had an estimated mass of 340,000 Da and likely consisted of a homodimer of the gp55-116 complex. By using a conformation-specific monoclonal antibody, postoligomerization folding of this molecule was demonstrated. This event exhibited an unusually prolonged half-maximal time of approximately 160 min. Both oligomerization and folding occurred in the endoplasmic reticulum. Oligomerization and folding occurred in the absence of carbohydrate modifications, although likely at lower efficiency. Finally, the oligomeric and folded forms were shown to be transported to the surface of infected cells and infectious virions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328688      PMCID: PMC240171     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  Regulation of protein export from the endoplasmic reticulum.

Authors:  J K Rose; R W Doms
Journal:  Annu Rev Cell Biol       Date:  1988

3.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

5.  The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

Authors:  M Urban; W Britt; M Mach
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants.

Authors:  L Pereira; M Hoffman; D Gallo; N Cremer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus.

Authors:  W J Britt
Journal:  Virology       Date:  1984-06       Impact factor: 3.616

Review 8.  Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

Authors:  M A Jacobson; J Mills
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

9.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

Authors:  N Singh; J S Dummer; S Kusne; M K Breinig; J A Armstrong; L Makowka; T E Starzl; M Ho
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

10.  Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport.

Authors:  M J Gething; K McCammon; J Sambrook
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

View more
  38 in total

1.  A protein-based therapeutic for human cytomegalovirus infection.

Authors:  F Jean; L Thomas; S S Molloy; G Liu; M A Jarvis; J A Nelson; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Sequence requirements for localization of human cytomegalovirus tegument protein pp28 to the virus assembly compartment and for assembly of infectious virus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Human cytomegalovirus glycoprotein B variants affect viral entry, cell fusion, and genome stability.

Authors:  Jiajia Tang; Giada Frascaroli; Robert J Lebbink; Eleonore Ostermann; Wolfram Brune
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

6.  Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.

Authors:  S Tugizov; E Maidji; J Xiao; Z Zheng; L Pereira
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.

Authors:  J Singh; T Compton
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.

Authors:  Nina Reuter; Barbara Kropff; Julia Karin Schneiderbanger; Mira Alt; Adalbert Krawczyk; Christian Sinzger; Thomas H Winkler; William J Britt; Michael Mach; Marco Thomas
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

9.  Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.

Authors:  M A Billstrom; W J Britt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.